547 related articles for article (PubMed ID: 10858956)
1. Signaling to p53: breaking the posttranslational modification code.
Appella E; Anderson CW
Pathol Biol (Paris); 2000 Apr; 48(3):227-45. PubMed ID: 10858956
[TBL] [Abstract][Full Text] [Related]
2. Post-translational modification of p53 and the integration of stress signals.
Meek DW
Pathol Biol (Paris); 1997 Dec; 45(10):804-14. PubMed ID: 9769944
[TBL] [Abstract][Full Text] [Related]
3. Post-translational modifications and activation of p53 by genotoxic stresses.
Appella E; Anderson CW
Eur J Biochem; 2001 May; 268(10):2764-72. PubMed ID: 11358490
[TBL] [Abstract][Full Text] [Related]
4. Posttranslational modifications affect the interaction of S100 proteins with tumor suppressor p53.
van Dieck J; Teufel DP; Jaulent AM; Fernandez-Fernandez MR; Rutherford TJ; Wyslouch-Cieszynska A; Fersht AR
J Mol Biol; 2009 Dec; 394(5):922-30. PubMed ID: 19819244
[TBL] [Abstract][Full Text] [Related]
5. Post-translational modification of p53 protein in response to ionizing radiation analyzed by mass spectrometry.
Abraham J; Kelly J; Thibault P; Benchimol S
J Mol Biol; 2000 Jan; 295(4):853-64. PubMed ID: 10656795
[TBL] [Abstract][Full Text] [Related]
6. Keratin modifications and solubility properties in epithelial cells and in vitro.
Omary MB; Ku NO; Liao J; Price D
Subcell Biochem; 1998; 31():105-40. PubMed ID: 9932491
[TBL] [Abstract][Full Text] [Related]
7. Induction of ser15 and lys382 modifications of p53 by blockage of transcription elongation.
Ljungman M; O'Hagan HM; Paulsen MT
Oncogene; 2001 Sep; 20(42):5964-71. PubMed ID: 11593403
[TBL] [Abstract][Full Text] [Related]
8. Acetylation and phosphorylation of the carboxy-terminal domain of p53: regulative significance.
Chiarugi V; Cinelli M; Magnelli L
Oncol Res; 1998; 10(2):55-7. PubMed ID: 9666512
[TBL] [Abstract][Full Text] [Related]
9. Regulation of p53 activity by HIPK2: molecular mechanisms and therapeutical implications in human cancer cells.
Puca R; Nardinocchi L; Givol D; D'Orazi G
Oncogene; 2010 Aug; 29(31):4378-87. PubMed ID: 20514025
[TBL] [Abstract][Full Text] [Related]
10. Advantage of a baculovirus expression system for protein-protein interaction studies. Involvement of posttranslational phosphorylation in the interaction between wt p53 protein and poly(ADP-ribose) polymerase-1.
Schmid G; Wojciechowski J; Wesierska-Gadek J
Acta Biochim Pol; 2005; 52(3):713-9. PubMed ID: 16082409
[TBL] [Abstract][Full Text] [Related]
11. p53 regulation by post-translational modification and nuclear retention in response to diverse stresses.
Jimenez GS; Khan SH; Stommel JM; Wahl GM
Oncogene; 1999 Dec; 18(53):7656-65. PubMed ID: 10618705
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53.
Sakaguchi K; Sakamoto H; Lewis MS; Anderson CW; Erickson JW; Appella E; Xie D
Biochemistry; 1997 Aug; 36(33):10117-24. PubMed ID: 9254608
[TBL] [Abstract][Full Text] [Related]
13. A serine 37 mutation associated with two missense mutations at highly conserved regions of p53 affect pro-apoptotic genes expression in a T-lymphoblastoid drug resistant cell line.
Cinti C; Claudio PP; Luca AD; Cuccurese M; Howard CM; D'Esposito M; Paggi MG; Sala DL; Azzoni L; Halazonetis TD; Giordano A; Maraldi NM
Oncogene; 2000 Oct; 19(44):5098-105. PubMed ID: 11042698
[TBL] [Abstract][Full Text] [Related]
14. The N terminus of the murine p53 tumour suppressor is an independent regulatory domain affecting activation and thermostability.
Hansen S; Lane DP; Midgley CA
J Mol Biol; 1998 Jan; 275(4):575-88. PubMed ID: 9466932
[TBL] [Abstract][Full Text] [Related]
15. On the mechanism of sequence-specific DNA-dependent acetylation of p53: the acetylation motif is exposed upon DNA binding.
Cesková P; Chichger H; Wallace M; Vojtesek B; Hupp TR
J Mol Biol; 2006 Mar; 357(2):442-56. PubMed ID: 16438982
[TBL] [Abstract][Full Text] [Related]
16. Methylation-acetylation interplay activates p53 in response to DNA damage.
Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
[TBL] [Abstract][Full Text] [Related]
17. DNA damage triggers DRB-resistant phosphorylation of human p53 at the CK2 site.
Blaydes JP; Hupp TR
Oncogene; 1998 Aug; 17(8):1045-52. PubMed ID: 9747884
[TBL] [Abstract][Full Text] [Related]
18. Activation of the DNA-binding ability of latent p53 protein by protein kinase C is abolished by protein kinase CK2.
Pospísilová S; Brázda V; Kucharíková K; Luciani MG; Hupp TR; Skládal P; Palecek E; Vojtesek B
Biochem J; 2004 Mar; 378(Pt 3):939-47. PubMed ID: 14640983
[TBL] [Abstract][Full Text] [Related]
19. The subcellular localization of vaccinia-related kinase-2 (VRK2) isoforms determines their different effect on p53 stability in tumour cell lines.
Blanco S; Klimcakova L; Vega FM; Lazo PA
FEBS J; 2006 Jun; 273(11):2487-504. PubMed ID: 16704422
[TBL] [Abstract][Full Text] [Related]
20. A cellular protein activates the sequence-specific DNA-binding of p53 by interacting with the central conserved region.
Srinivasan R; Maxwell SA
Oncogene; 1996 Jan; 12(1):193-200. PubMed ID: 8552392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
